{
    "clinical_study": {
        "@rank": "50175", 
        "acronym": "CT_TKA", 
        "arm_group": [
            {
                "arm_group_label": "4 weekly CT sessions - in person", 
                "arm_group_type": "Experimental", 
                "description": "4 weekly CT sessions; all will be 1-hr individual cognitive therapy sessions with the psychology staff (under the supervision of John Burns, PhD)."
            }, 
            {
                "arm_group_label": "8 weekly CT sessions", 
                "arm_group_type": "Experimental", 
                "description": "8 weekly CT sessions; 1st and 8th will be 1-hr individual cognitive therapy session with the psychology staff (under the supervision of John Burns, PhD). The intermediate CT sessions will be by telephone call or video/skype. Our group will purchase and setup a web camera and headphone/microphone for the subjects in the CT groups that use skype. The 1-hr CT protocol was adapted from Dr. Beverly E. Thorn's CT manual (Cognitive Therapy for Chronic Pain: A Step-by-Step Guide; Thorn, 2004; with the Client and Therapy Workbooks."
            }, 
            {
                "arm_group_label": "4 weekly CT sessions - Tele-video", 
                "arm_group_type": "Experimental", 
                "description": "4 weekly CT sessions; 1st and 4th will be 1-hr individual cognitive therapy session with the psychology staff. The intermediate CT sessions will be by telephone call or video/Skype."
            }, 
            {
                "arm_group_label": "Routine care", 
                "arm_group_type": "Placebo Comparator", 
                "description": "Routine care; no CT sessions"
            }
        ], 
        "brief_summary": {
            "textblock": "The investigators propose a randomized controlled trial to evaluate the effects of treatment\n      intended to reduce pain catastrophizing among patients reporting high pain catastrophizing\n      prior to total knee replacement(TKR) in an effort to thereby reduce the incidence of\n      persistent post-surgical pain (PPP) and enhance physical function at 3-months post-surgery.\n      Preemptive treatment aimed at a known predictor of PPP following total knee replacement is\n      highly innovative and have potentially high impact for public health.  Cognitive therapy is\n      a well-tolerated modality among chronic pain patients with few if any side effects.\n      Cognitive therapy (CT) represents an inexpensive method that could greatly reduce suffering\n      and costly post-surgical pain management for high risk TKR patients."
        }, 
        "brief_title": "Preoperative Cognitive Therapy for Improving Health Outcomes After Total Knee Replacement in High-risk Catastrophizing Subjects", 
        "completion_date": {
            "#text": "January 2015", 
            "@type": "Anticipated"
        }, 
        "condition": "Catastrophization", 
        "detailed_description": {
            "textblock": "Aim 1 is to determine which CT protocol is most effective in reducing Pain Catastrophizing\n      Scale (PCS) and Coping Strategies Questionnaire Catastrophizing Subscale (CSQ-CAT) scores in\n      high-risk TKR candidates. CT will consist of four-to-eight weekly 1-hr individual cognitive\n      therapy sessions prior to surgery."
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          1. undergoing standard tricompartmental primary TKR;\n\n          2. 18- 85 yrs of age;\n\n          3. joint to be replaced is the primary source of patient's pain;\n\n          4. patient agrees to preoperative visits and treatment, follow-up visits and treatment,\n             and to comply with the assessment tests;\n\n          5. patient consents to standard anesthetic and analgesic protocol, with medical care as\n             deemed necessary by the anesthesiologist, and has no contraindications.\n\n          6. Patient has been diagnosed with osteoarthritis.\n\n        Exclusion Criteria:\n\n          1. Currently using antidepressant medication or undergoing cognitive therapy;\n\n          2. chronic opioid use \u2265 10 mg/day of morphine equivalents within one wk prior to the\n             surgery, and duration of use > 4 wks;\n\n          3. history of opioid abuse;\n\n          4. inability to understand and communicate with the investigators to complete the study\n             related questionnaires\n\n          5. patient currently enrolled in another study;\n\n          6. patient is planning to undergo another elective joint replacement procedure during\n             the 6-mo period of participation;\n\n          7. any co-morbidity which results in severe systemic disease limiting function {as\n             defined by the American Society of Anesthesiology (ASA) physical status\n             classification > 3}."
            }, 
            "gender": "Both", 
            "healthy_volunteers": "Accepts Healthy Volunteers", 
            "maximum_age": "85 Years", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "80", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "January 17, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01772329", 
            "org_study_id": "12031901"
        }, 
        "intervention": {
            "arm_group_label": [
                "4 weekly CT sessions - in person", 
                "8 weekly CT sessions", 
                "4 weekly CT sessions - Tele-video"
            ], 
            "description": "CT will be used as a preemptive treatment in an effort to minimize the effects of catastrophic thinking.", 
            "intervention_name": "Cognitive Therapy", 
            "intervention_type": "Other"
        }, 
        "is_fda_regulated": "No", 
        "lastchanged_date": "August 21, 2013", 
        "location": {
            "contact": {
                "email": "Heather_Orluske@rush.edu", 
                "last_name": "Heather Orluske, RN, BSN", 
                "phone": "312-942-2741"
            }, 
            "facility": {
                "address": {
                    "city": "Chicago", 
                    "country": "United States", 
                    "state": "Illinois", 
                    "zip": "60612"
                }, 
                "name": "Rush University Medical Center"
            }, 
            "investigator": {
                "last_name": "Asokumar Buvanendran, MD", 
                "role": "Principal Investigator"
            }, 
            "status": "Recruiting"
        }, 
        "location_countries": {
            "country": "United States"
        }, 
        "number_of_arms": "4", 
        "official_title": "Preoperative Cognitive Therapy for Improving Health Outcomes After Total Knee Replacement in High-risk Catastrophizing Subjects", 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": "United States: Institutional Review Board", 
            "has_dmc": "No"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "January 2015", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "measure": "Pain Catastrophizing Scale (PCS)", 
            "safety_issue": "No", 
            "time_frame": "4 or 8 weeks after start of treatment"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01772329"
        }, 
        "responsible_party": {
            "investigator_affiliation": "Rush University Medical Center", 
            "investigator_full_name": "Asokumar Buvanendran", 
            "investigator_title": "Profesor Anesthesiology", 
            "responsible_party_type": "Principal Investigator"
        }, 
        "secondary_outcome": [
            {
                "description": "Patient Health Questionnaire (PHQ-8): The eight-item Patient Health Questionnaire depression scale (PHQ-8) is established as a valid diagnostic and severity measure for depressive disorders", 
                "measure": "Patient Health Questionnaire (PHQ-8)", 
                "safety_issue": "No", 
                "time_frame": "4 and 8 weeks after start of treatment"
            }, 
            {
                "description": "Generalized anxiety disorder (GAD-7): The seven-item Generalized Anxiety Disorder Scale (GAD-7) is a practical self-report anxiety questionnaire.", 
                "measure": "Generalized anxiety disorder (GAD-7)", 
                "safety_issue": "No", 
                "time_frame": "4 and 8 weeks after start of treatment"
            }
        ], 
        "source": "Rush University Medical Center", 
        "sponsors": {
            "collaborator": {
                "agency": "Pfizer", 
                "agency_class": "Industry"
            }, 
            "lead_sponsor": {
                "agency": "Rush University Medical Center", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "January 2013", 
        "study_design": "Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Single Blind (Investigator), Primary Purpose: Prevention", 
        "study_type": "Interventional", 
        "verification_date": "January 2013"
    }
}